BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 872 filers reported holding BAXTER INTL INC in Q2 2016. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $213,000 | -17.4% | 3,322 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $258,000 | -2.3% | 3,322 | +8.1% | 0.00% | 0.0% |
| Q4 2021 | $264,000 | +6.9% | 3,074 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $247,000 | 0.0% | 3,074 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $247,000 | -4.6% | 3,074 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $259,000 | -5.5% | 3,074 | -9.9% | 0.01% | 0.0% |
| Q4 2020 | $274,000 | 0.0% | 3,410 | 0.0% | 0.01% | -16.7% |
| Q3 2020 | $274,000 | -6.8% | 3,410 | 0.0% | 0.01% | -14.3% |
| Q2 2020 | $294,000 | +1.4% | 3,410 | -4.7% | 0.01% | -12.5% |
| Q1 2020 | $290,000 | -41.8% | 3,578 | -40.0% | 0.01% | -27.3% |
| Q4 2019 | $498,000 | +26.4% | 5,960 | +32.4% | 0.01% | +22.2% |
| Q3 2019 | $394,000 | +6.8% | 4,500 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $369,000 | +0.8% | 4,500 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $366,000 | +14.4% | 4,500 | -7.4% | 0.01% | 0.0% |
| Q4 2018 | $320,000 | -44.7% | 4,859 | -35.3% | 0.01% | -35.7% |
| Q3 2018 | $579,000 | +7.2% | 7,511 | +2.6% | 0.01% | 0.0% |
| Q2 2018 | $540,000 | +13.4% | 7,321 | 0.0% | 0.01% | +16.7% |
| Q1 2018 | $476,000 | +0.6% | 7,321 | 0.0% | 0.01% | -7.7% |
| Q4 2017 | $473,000 | +3.7% | 7,321 | +0.8% | 0.01% | +8.3% |
| Q3 2017 | $456,000 | +3.6% | 7,262 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $440,000 | -3.3% | 7,262 | -17.2% | 0.01% | -7.7% |
| Q1 2017 | $455,000 | +9.6% | 8,769 | -6.2% | 0.01% | +8.3% |
| Q4 2016 | $415,000 | -5.7% | 9,348 | +1.3% | 0.01% | -20.0% |
| Q3 2016 | $440,000 | -15.7% | 9,224 | -20.1% | 0.02% | -6.2% |
| Q2 2016 | $522,000 | +9.9% | 11,550 | 0.0% | 0.02% | +6.7% |
| Q1 2016 | $475,000 | +6.7% | 11,550 | -0.9% | 0.02% | +7.1% |
| Q4 2015 | $445,000 | +21.9% | 11,650 | +5.0% | 0.01% | +16.7% |
| Q3 2015 | $365,000 | -55.0% | 11,090 | -4.3% | 0.01% | -52.0% |
| Q2 2015 | $811,000 | +2.5% | 11,590 | +0.3% | 0.02% | +4.2% |
| Q1 2015 | $791,000 | -6.6% | 11,550 | 0.0% | 0.02% | -4.0% |
| Q4 2014 | $847,000 | -39.1% | 11,550 | -40.4% | 0.02% | -40.5% |
| Q3 2014 | $1,391,000 | +5.2% | 19,380 | +5.9% | 0.04% | 0.0% |
| Q2 2014 | $1,322,000 | -2.2% | 18,300 | -0.4% | 0.04% | -2.3% |
| Q1 2014 | $1,352,000 | +23.7% | 18,380 | +17.0% | 0.04% | +22.9% |
| Q4 2013 | $1,093,000 | +5.6% | 15,715 | -0.3% | 0.04% | 0.0% |
| Q3 2013 | $1,035,000 | -4.9% | 15,755 | +0.4% | 0.04% | -10.3% |
| Q2 2013 | $1,088,000 | – | 15,700 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |